T 1672/09 (HSV Complex/ MEDIGENE) of 05.09.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T167209.20130905
- Date of decision
- 5 September 2013
- Case number
- T 1672/09
- Online on
- 14 October 2013
- Petition for review of
- -
- Application number
- 03739561.3
- IPC class
- C12N 15/86
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- An herpes simplex virus complex
- Applicant name
- Virttu Biologics Limited
- Opponent name
- MediGene Aktiengesellschaft
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56
- Keywords
- Main request - added matter (no), inventive step (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
ORDER:
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as amended in the following version:
Page 3 and pages 5 to 7 of the patent specification as granted. Pages 2 and 4 of the amended patent specification filed at the oral proceedings before the Board on 5 September 2013.
Claims 1-39 of the Main Request filed at the oral proceedings before the Board on 5 September 2013.
Figures 1 - 5 of the patent as granted.